Trexquant Investment’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.1M Sell
41,788
-7,728
-16% -$1.25M 0.04% 612
2026
Q2
$7.62M Buy
49,516
+34,444
+229% +$5.28M 0.04% 550
2026
Q1
$2.4M Buy
+15,072
New +$2.53M 0.02% 927

Other funds holding BLTE

Trexquant Investment's BLTE Position: Q3 2026 in Review

Trexquant Investment reduced its Belite Bio (BLTE) stake by 16% in Q3 2026, selling an estimated $1.25M and leaving 41,788 shares worth $7.1M. The position accounts for 0.04% of the portfolio, ranked #612.

Trexquant Investment first reported a position in BLTE in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.62M in Q2 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Trexquant Investment held 41,788 shares of Belite Bio worth $7.1M as of Q3 2026.
  • Trexquant Investment sold 7,728 Belite Bio shares in Q3 2026, an estimated $1.25M.
  • Belite Bio made up 0.04% of Trexquant Investment's portfolio in Q3 2026, its #612 holding.
  • Trexquant Investment first reported a position in Belite Bio in Q1 2026 and has held it in 3 quarters since.
  • Trexquant Investment's Belite Bio position peaked at $7.62M in Q2 2026.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.